Sidoti Raises Cantel Medical to Buy (CMN)

By admin | 6 years ago

Cantel Medical (NYSE: CMN) was upgraded by investment analysts at Sidoti from a “neutral” rating to a “buy” rating in a note issued to investors on Monday.

Shares of Cantel Medical traded up 0.67% during mid-day trading on Monday, hitting $22.40. Cantel Medical has a one year low of $12.68 and a one year high of $25.55. The company has a market cap of $591.7 million and a P/E ratio of 25.60.

Cantel Medical last issued its quarterly earnings data on Thursday, March 8th. The company reported $0.27 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.25 by $0.02. Cantel Medical’s revenue was up 20.1% compared to the same quarter last year. On average, analysts predict that Cantel Medical will post $0.29 earnings per share next quarter.

Separately, analysts at Needham & Company raised their price target on shares of Cantel Medical from $22.00 to $26.00 in a research note to investors on Friday, March 9th. They now have a “buy” rating on the stock.

Cantel Medical Corp. (Cantel) is a provider of infection prevention and control products and services in the healthcare market.

About the author